1 School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, China 2 School of Traditional Chinese Medicine Health Preservation, Guizhou University of Traditional Chinese ...

Fintel reports that on November 5, 2024, RBC Capital downgraded their outlook for Verrica Pharmaceuticals (NasdaqGM:VRCA) ...

Additionally, there is an anticipation that demand-driven sales will normalize in early 2025, aligning with the discontinuation of compounded cantharidin. Although near-term revenue estimates have ...

Company reported $0 in product shipments in the third quarter of 2024 and recognized negative net product revenue of $1.9 million, including a ...

Cantharidin: The blister-inducing agent Cantharidin, a chemical applied by healthcare providers, offers another effective treatment option. It causes a blister to form beneath the wart ...

Fintel reports that on November 6, 2024, HC Wainwright & Co. downgraded their outlook for Verrica Pharmaceuticals (NasdaqGM:VRCA) from Buy to Neutral. Analyst Price Forecast Suggests 1,688.99% Upside ...

During the first three quarters of 2024, Ycanth recorded sales of $6.3 million. Ycanth, is a proprietary drug-device ...

On October 1, 2024, the Company completed a restructuring of its commercial operations to reduce expenses and optimize the efficiency of its field force by reducing the number of sales territories and ...

The Food and Drug Administration (FDA) has approved two topical agents for the treatment of MC: Ycanth (cantharidin) is a topical treatment for people aged 2 and older. It is applied by your ...

10. Blister Beetles Blister beetles produce cantharidin, a toxin that causes skin blistering. Research in Toxicon has shown that cantharidin can lead to serious health issues if ingested or ...

Pediatr Infect Dis J. 2008;27(6):551-552. Eczema, also known as atopic dermatitis, is a chronic skin condition which affects 15-20% of the population in developed countries including the United ...